STOCK TITAN

Clene reported $200K in revenue and a $26.2M net loss for fiscal 2025. See the full CLNN financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

Clene to Present at Upcoming September Investor Conferences

Clene (CLNN) will present at two September 2026 investor conferences and host one-on-one investor meetings.

(Moderate)
(Neutral)
Tags

Clene (CLNN) will present at two September 2026 investor conferences and host one-on-one investor meetings.

The company presents at the 2026 Cantor Global Healthcare Conference/b) on at 9:10 a.m. ET in New York, and at the HC Wainwright 28th Annual Global Investment Conference on September 15, 2026 at 1:30 p.m. ET, also in New York. Webcasts will be available via Clene’s website “Events” section or the provided webcast links.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Context

Prior Clene presentation announcements produced +1.45% on August 17 and -5.41% on July 29. This mixe...
Analysis

Prior Clene presentation announcements produced +1.45% on August 17 and -5.41% on July 29. This mixed record adds context to the scheduling notice; the resale registration provides no company proceeds and includes going-concern risk disclosure.

Key Figures

Cantor presentation date: September 9, 2026 Cantor presentation time: 9:10am ET H.C. Wainwright presentation date: September 15th, 2026 +2 more
5 metrics
Cantor presentation date September 9, 2026 2026 Cantor Global Healthcare Conference
Cantor presentation time 9:10am ET 2026 Cantor Global Healthcare Conference
H.C. Wainwright presentation date September 15th, 2026 H.C. Wainwright 28th Annual Global Investment Conference
H.C. Wainwright presentation time 1:30pm ET H.C. Wainwright 28th Annual Global Investment Conference
Meeting format 1x1 investor meetings Both investor conferences

Historical Context

5 past events · Latest: Aug 17 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Aug 17 Investor presentation Neutral +1.4% Emerging Growth Conference presentation and investor meetings announcement
Aug 14 2Q26 earnings Negative -1.2% Quarterly results, financing developments, and ALS regulatory update
Aug 10 Clinical data Positive -2.3% Biomarker analyses supporting planned ALS accelerated approval submission
Jul 29 Investor presentation Neutral -5.4% Canaccord conference presentation and investor meetings announcement
May 14 1Q26 earnings Positive +8.5% Regulatory progress and first-quarter financial results announcement

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent presentation announcements produced mixed reactions, ranging from a 1.45% gain on August 17 to a 5.41% decline on July 29.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SALT LAKE CITY, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) today announced that management will present at the 2026 Cantor Global Healthcare Conference and at the H.C. Wainwright 28th Annual Global Investment Conference and host 1x1 investor meetings at both conferences.

2026 Cantor Global Healthcare Conference
Date: September 9, 2026
Time of Presentation: 9:10am ET
Location: New York, NY
Format: Presentation and 1x1 meetings
1x1 Meetings: Please contact your Cantor representative
Webcast: link to webcast

HC Wainwright 28th Annual Global Investment Conference
Date: September 15th, 2026
Time of Presentation: 1:30pm ET
Location: New York, NY
Format: Presentation and 1x1 meetings
1x1 Meetings: Please contact your H.C. Wainwright representative
Webcast: link to webcast

A webcast of the presentation will be available on the “Events” section of the Clene website or using the webcast links above.

About Clene
Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis. CNM-Au8® is an investigational first-in-class therapy that improves central nervous system cells’ survival and function via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8® is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.clene.com or follow us on X (formerly Twitter) and LinkedIn.

Investor Contact: Kevin Gardner, LifeSci Advisors; kgardner@lifesciadvisors.com; 617-283-2856
Media Contact: Caroline Wagner, FTP; CWagner@ftpadvocacy.com; (267) 294-6563 


FAQ

When will Clene (CLNN) present at the 2026 Cantor Global Healthcare Conference?

Clene is scheduled to present at the 2026 Cantor Global Healthcare Conference on September 9, 2026 at 9:10 a.m. ET in New York, New York. The format includes a presentation and one-on-one investor meetings.

What are the details of Clene (CLNN)’s presentation at the HC Wainwright 28th Annual Global Investment Conference?

Clene will present at the HC Wainwright 28th Annual Global Investment Conference on September 15, 2026 at 1:30 p.m. ET in New York, New York. The company will give a presentation and hold one-on-one investor meetings.

How can investors schedule 1x1 meetings with Clene (CLNN) at these September 2026 conferences?

For the 2026 Cantor Global Healthcare Conference, investors should contact their Cantor representative to arrange one-on-one meetings. For the HC Wainwright 28th Annual Global Investment Conference, investors should contact their H.C. Wainwright representative to schedule 1x1 meetings with Clene.

How can investors access the webcasts of Clene (CLNN)’s September 2026 conference presentations?

Webcasts of Clene’s presentations at both the Cantor Global Healthcare Conference and the HC Wainwright 28th Annual Global Investment Conference will be available on the “Events” section of Clene’s website or through the specific webcast links provided for each conference.